Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...
Mar 18, 2026
0
24
Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But as more people live into their 60s, 70s, and 80s, health care systems across the globe may face new challenges ...
Mar 30, 2026
0
24
When the stomach is full, how does the brain know to stop eating? Scientists long assumed the answer lies mainly with neurons, the brain's primary signaling cells. But a new study published in the Proceedings of the National ...
Apr 7, 2026
0
24
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according ...
Feb 25, 2026
0
23
Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally intended, but by retraining ...
Feb 27, 2026
0
23
A long-term MRI study demonstrates that lower accumulation of abdominal fat (visceral fat), measured throughout the entire follow-up period, is associated with a significant slowing of brain atrophy, preservation of key brain ...
May 4, 2026
0
23
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have discovered how disruptions in ...
Mar 9, 2026
0
23
While most parents know to limit candy, the true danger of sugar in a child's diet is often hidden in plain sight. A growing body of research reveals that excessive sugar consumption in childhood is linked to a frightening ...
Feb 20, 2026
0
22
Intermittent fasting has become a buzzword in nutrition circles, with many people looking to it as a way to lose weight or improve their health.
Feb 21, 2026
0
22
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
May 17, 2026
0
22
